All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 1980-03-28? to Wed 2025-12-24 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
+46.81%
2025-12-24 |
107.04 TRR
2025-12-24 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Wed 2025-12-24 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+10,603.98%
+10.76%/yr |
+7.72%/yr
(R2=0.689) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Wed 2025-12-24 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1980-03-28 |
$1,070,397.90
2025-12-24 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2025 (YTD) | +46.81% |
| 2024 | −7.82% |
| 2023 | +6.16% |
| 2022 | −21.82% |
| 2021 | +18.42% |
| 2020 | −18.81% |
| 2019 | +26.37% |
| 2018 | +11.67% |
| 2017 | −5.00% |
| 2016 | +0.03% |
| 2015 | −1.00% |
| 2014 | −16.32% |
| 2013 | +27.02% |
| 2012 | −1.05% |
| 2011 | +19.07% |
| 2010 | −3.57% |
| 2009 | +16.19% |
| 2008 | −22.36% |
| 2007 | −4.65% |
| 2006 | +5.28% |
| 2005 | +6.22% |
| 2004 | +2.30% |
| 2003 | +26.39% |
| 2002 | −23.43% |
| 2001 | −11.00% |
| 2000 | +0.72% |
| 1999 | −20.05% |
| 1998 | +45.81% |
| 1997 | +53.21% |
| 1996 | +14.15% |
| 1995 | +41.67% |
| 1994 | +0.44% |
| 1993 | −12.82% |
| 1992 | −25.10% |
| 1991 | +93.00% |
| 1990 | +22.94% |
| 1989 | +32.55% |
| 1988 | +2.47% |
| 1987 | +15.84% |
| 1986 | +42.44% |
| 1985 | +80.32% |
| 1984 | +26.23% |
| 1983 | −5.43% |
| 1982 | +149.10% |
| 1981 | +15.74% |
| 1980 | +15.87% |
| Fri 1980-03-28? to Wed 2025-12-24 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −99.99% |
−100.00%
1985-09-30 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||